Search Results - "Fujii, Yasuo"

Refine Results
  1. 1

    Relationship between polydipsia and antipsychotics: A systematic review of clinical studies and case reports by Kirino, So, Sakuma, Mutsuki, Misawa, Fuminari, Fujii, Yasuo, Uchida, Hiroyuki, Mimura, Masaru, Takeuchi, Hiroyoshi

    “…This systematic review aimed to elucidate the relationship between polydipsia and antipsychotics. We systematically searched MEDLINE, Embase, and PsycINFO, and…”
    Get full text
    Journal Article
  2. 2

    What Lessons Should We Learn from the Death of Patients on Xeplion? by Fujii, Yasuo

    “…From the launch of the long-acting injectable antipsychotic paliperidone palmitate (XEPLION) on November 19, 2013, 32 fatal cases had been reported up to May…”
    Get more information
    Journal Article
  3. 3

    Suppression of conflict between Human and Machine by Human-Centered Shared Control by MASUDA, Kei, FUJII, Yasuo, MOURI, Hiroshi

    “…It will take a long time to put autonomous driving into practical in city road. Because the reliability of the technology for collecting traffic environment…”
    Get full text
    Journal Article
  4. 4

    Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study by Misawa, Fuminari, Shimizu, Keiko, Fujii, Yasuo, Miyata, Ryouji, Koshiishi, Fumio, Kobayashi, Mihoko, Shida, Hirokazu, Oguchi, Yoshiyo, Okumura, Yasuyuki, Ito, Hiroto, Kayama, Mami, Kashima, Haruo

    Published in BMC psychiatry (26-07-2011)
    “…Although the validity and safety of antipsychotic polypharmacy remains unclear, it is commonplace in the treatment of schizophrenia. This study aimed to…”
    Get full text
    Journal Article
  5. 5

    Reintroduction of Clozapine After Perforation of the Large Intestine—A Case Report and Review of the Literature by Ikai, Saeko, Suzuki, Takefumi, Uchida, Hiroyuki, Mimura, Masaru, Fujii, Yasuo

    Published in The Annals of pharmacotherapy (01-07-2013)
    “…OBJECTIVE To report on a patient who was successfully rechallenged with clozapine after perforation of the large intestine and pulmonary embolism…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan by Misawa, Fuminari, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in The journal of clinical psychiatry (01-09-2022)
    “…Objective: This study compared the reporting frequency of tardive dyskinesia (TD) between long-acting injectable antipsychotics (LAI-APs) and the equivalent…”
    Get full text
    Journal Article
  8. 8

    Mortality in patients with schizophrenia in Japan by Nomura, Nobuyuki, Misawa, Fuminari, Fujii, Yasuo, Takeuchi, Hiroyoshi

    “…Purpose Patients with schizophrenia have a higher mortality risk than the general population. However, no recent studies have investigated mortality in…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Appendicitis Associated With Clozapine: Analyses Based on a Spontaneous Reporting System Database in Japan by Misawa, Fuminari, Nakajima, Nozomi, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in Journal of clinical psychopharmacology (01-05-2023)
    “…An association between appendicitis and clozapine has recently been reported; however, few studies other than case reports have investigated this association…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan by Misawa, Fuminari, Okumura, Yasuyuki, Takeuchi, Yoshinori, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in Schizophrenia research (01-05-2021)
    “…Long-acting injectable antipsychotics (LAI-APs) remain underutilized. One reason is the concern that LAI-APs might cause serious adverse events such as…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics: A Retrospective Chart Review and Prescribers' Attitude Survey by Misawa, Fuminari, Amemiya, Ami, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in Journal of clinical psychopharmacology (01-01-2022)
    “…Although long-acting injectable antipsychotics (LAI-APs) have been considered as a monotherapeutic option in the maintenance treatment of schizophrenia, it has…”
    Get full text
    Journal Article
  16. 16

    Risk of withdrawal of consent for treatment with long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled trials by Yaegashi, Hodaka, Misawa, Fuminari, Noda, Hokuto, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in Schizophrenia research (01-03-2021)
    “…Despite the clinical importance of antipsychotic long-acting injections (LAIs) in the treatment of schizophrenia, their use may be limited by patients'…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Olanzapine Reduction From High Dose to Standard Dose: A Retrospective Chart Review by Okeya, Komugi, Misawa, Fuminari, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in Journal of clinical psychopharmacology (01-11-2021)
    “…Although high-dose olanzapine might be a treatment option in patients with treatment-resistant schizophrenia, it can be reduced to the standard dose after…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Clinical outcomes after clozapine discontinuation in responders versus nonresponders: a retrospective chart review by Watanabe, Maiko, Misawa, Fuminari, Miura, Gentaro, Fujii, Yasuo, Takeuchi, Hiroyoshi

    Published in International clinical psychopharmacology (01-07-2021)
    “…No studies have compared clinical outcomes after discontinuation of clozapine between patients who responded to clozapine and those who did not. Therefore, we…”
    Get full text
    Journal Article